ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $23,000 | -25.8% | 11,000 | -22.5% | 0.00% | – |
| Q3 2019 | $31,000 | -8.8% | 14,200 | +5.2% | 0.00% | – |
| Q2 2019 | $34,000 | -67.3% | 13,500 | -55.0% | 0.00% | – |
| Q1 2019 | $104,000 | +52.9% | 30,000 | +1.7% | 0.00% | – |
| Q4 2018 | $68,000 | +17.2% | 29,500 | +96.7% | 0.00% | – |
| Q3 2018 | $58,000 | -72.6% | 15,000 | -67.4% | 0.00% | – |
| Q3 2017 | $212,000 | +118.6% | 46,000 | +2.2% | 0.00% | – |
| Q2 2017 | $97,000 | -31.7% | 45,000 | 0.0% | 0.00% | – |
| Q1 2017 | $142,000 | +21.4% | 45,000 | 0.0% | 0.00% | – |
| Q4 2016 | $117,000 | +20.6% | 45,000 | +80.0% | 0.00% | – |
| Q3 2016 | $97,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |